Treatment Option and Patient Preferences Keys to Decision Making for Emotional Well Being – Presented at San Antonio Breast Cancer Symposium (SABCS) – December 7, 2018
CAMBRIDGE, Mass. and SAN ANTONIO, Texas and Mumbai, INDIA – Dec. 7, 2018 – Navya, a clinical informatics and cancer patient services company, founded by graduates of Harvard, MIT Sloan and Stanford in conjunction with Tata Memorial Centre (TMC) and National Cancer Grid (NCG), has been invited to present this impactful study at the 2018 San Antonio Breast Cancer Symposium (SABCS).
Navya’s patented system uses clinical informatics, predictive analytics and machine learning. These technologies, which were validated with clinical experts and presented at SABCS 2014, provide patients an upper hand to assess a cancer care decision for themselves, while making available an easy, quick, and preliminary treatment decision pathway, based on an evidence and experience based system, thereby relieving patient anxiety. These are key features of the study being presented at this year’s SABCS.
Promising results have been obtained from patients who have used the Navya Online Expert Opinion System, having been provided with evidence and experience based preliminary reports and expert opinions.
Dr. Shalaka Joshi is presenting, “Accuracy of psychosocial assessment in an online surgical decision aid developed for early breast cancer patients with resource and educational constraints” – Friday, December 7, 2018, 5-7pm.
Navya’s presentation focuses on the good response which has been received from women with early-stage breast cancer using the Navya Patient Preference Tool (PPT), which consists of an easy to understand questionnaire, making it simple to understand complex surgical treatment decisions. Women from socioeconomic backgrounds with resource constraints are commonly not explained the options they have, and hence allowed only limited opinion in their treatment decision making.
“Every patient should be able to advocate her own treatment decisions,” stated Dr. Rajendra Badwe, Director of Tata Memorial Centre and Principal Investigator of the Randomized Controlled Trial on Navya Patient Preference Tools. “By using the Navya PPT, women are able to assess risk-benefit tradeoffs and determine their decision irrespective of education and resource constraints, along with their family and treating oncologist. Decision Aids such as Navya PPT, which account for psychosocial confounders of agency, have the potential to benefit women otherwise marginalized from shared decision making and is especially relevant for women to enable them to be a party to the decision making on matters related to their health and their body.”
About Tata Memorial Centre
Tata Memorial Centre, founded in 1941, leads the Indian subcontinent in cancer care by evidence based practice of oncology, and research and services which are affordable, innovative, and relevant to the needs of the country. Every year nearly 10 million patients visit TMC from all over India and developing countries in Asia, Africa. Approximately, 70 percent of these patients are treated almost free of charge. Visit: https://tmc.gov.in.
In 2009, Navya was founded in Cambridge, MA by graduates of Harvard, MIT Sloan, and Stanford. Navya’s patented system uses clinical informatics, predictive analytics and machine learning technologies. It combines several clinical information sources as inputs – and outputs a treatment decision most applicable to a unique patient. For the first time, quick and affordable access to evidence and experience based expert treatment decisions is available to every cancer patient. Navya’s Online Expert Opinion Service has been used by over 26,000 patients in 67 countries.
Visit: Navya Online
Navya Twitter Navya Facebook Navya LinkedIn
All trademarks recognized.